Close Menu

Sunquest Information Systems

The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.

According to Sunquest, UniConnect's technology will augment its own existing solutions for molecular diagnostics.

The deal provides Clinical Genomics with a "cornerstone piece" as it readies its blood-based test for colorectal cancer recurrence for commercialization in the US later this year.

Tute has partnered with LIMS provider UniConnect to build infrastructure to support gene panels for mitochondrial, metabolic, and other genetic diseases.

Tute will provide its cloud-based informatics and genome analysis platform to support two new NGS testing panels that NSO is developing.

NEW YORK (GenomeWeb) – UniConnect said this week that Children's Hospital Colorado's molecular diagnostics laboratory has deployed its Precision Molecular Diagnostics (PMDx) laboratory information system.

NEW YORK (GenomeWeb) — UniConnect last week unveiled PrecisionMDx, a specialized version of its flagship UniFlow laboratory process management software for molecular testing laboratories.

NEW YORK (GenomeWeb) – Utah-based software firm UniConnect said this week that it will donate UniFlow, its laboratory process management software, to George Washington University's Computational Biology Institute (CBI).

Selah Genomics has licensed UniFlow, UniConnect's laboratory information management system, to manage molecular and clinical data for its clinical diagnostic services business.

UniConnect said recently that Dupont Pioneer is using its UniFlow laboratory information management software system to support ongoing efforts to develop new plant products that have higher yields and are more resistant to pests and diseases.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.